CD274 and metastatic melanoma: Studies have shown that in patients with metastatic melanoma treated with anti-PD-1 therapy, circulating exosome PD-L1 levels are positively correlated with interferon-γ (IFN-γ) signaling, which can stimulate PD-L1 expression (58).